"BLS is projecting revenue growth in individual product categories in the next two quarters of
between 30% to 50%."
Seems to be at odds with the previous revenue guidanace with no growth in the HY2.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
BXN
bioxyne limited
Add to My Watchlist
6.67%
!
3.2¢

"BLS is projecting revenue growth in individual product...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.2¢ |
Change
0.002(6.67%) |
Mkt cap ! $69.27M |
Open | High | Low | Value | Volume |
3.1¢ | 3.2¢ | 3.0¢ | $28.21K | 918.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 202464 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 330874 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 202464 | 0.031 |
5 | 1395621 | 0.030 |
5 | 1268948 | 0.029 |
8 | 2188077 | 0.028 |
8 | 1128573 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 296874 | 1 |
0.033 | 503409 | 3 |
0.034 | 1112100 | 6 |
0.035 | 780479 | 4 |
0.036 | 801345 | 3 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
BXN (ASX) Chart |